Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor

被引:24
|
作者
Tomoo, Koji [1 ]
机构
[1] Osaka Univ Pharmaceut Sci, Dept Phys Chem, Osaka 5691094, Japan
关键词
LYSOSOMAL CYSTEINE PROTEASES; RAY CRYSTAL-STRUCTURE; MALIGNANT PROGRESSION; OCCLUDING LOOP; PAPAIN; COMPLEX; BINDING; IDENTIFICATION; POTENT; E-64;
D O I
10.2174/156802610791113441
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cathepsins are a family of lysosomal cysteine proteases that are abundant in living cells and play important roles in intracellular proteolysis. Cathepsins are necessary for cell survival, and disruption of regulation of the activity of these enzymes causes serious diseases including allergy, atherosclerosis, muscular dystrophy, Alzheimer's disease and cancer. Therefore, the design of inhibitors for cathepsins is important in development of therapeutic agents. This review will focus on the features of the tertiary structure and substrate-binding specificity of cathepsins B, L, S and K, based on X-ray crystal structures of their complexes with inhibitors. To illustrate an approach to drug design, an example of structure-based design of a cathepsin B-specific inhibitor is described.
引用
收藏
页码:696 / 707
页数:12
相关论文
共 50 条
  • [41] Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C
    Korkmaz, Brice
    Lesner, Adam
    Wysocka, Magdalena
    Gieldon, Artur
    Hakansson, Maria
    Gauthier, Francis
    Logan, Derek T.
    Jenne, Dieter E.
    Lauritzen, Conni
    Pedersen, John
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 349 - 367
  • [42] THERMOSTABLE ENDOGENOUS INHIBITORS OF CATHEPSIN-B AND CATHEPSIN-H
    LENNEY, JF
    TOLAN, JR
    SUGAI, WJ
    LEE, AG
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 101 (01): : 153 - 161
  • [43] The propeptide of human cathepsin S is a powerful and specific inhibitor of cathepsin S activity
    Maubach, G
    Schilling, K
    Wenz, I
    Rommerskirch, W
    Wiederanders, B
    PROTEOLYSIS IN CELL FUNCTIONS, 1997, 13 : 167 - 173
  • [44] Development of small molecule inhibitors of cathepsin B as antimetastatic agents
    Dana, Dibyendu
    Kumar, Sanjai
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [45] Development and evaluation of new cathepsin B inhibitors containing thiosemicarbazones
    Steele, Keegan
    Rahman, Franklin
    Sutton, Valerie
    Rizvi, Omar
    Kadasala, Naveen Reddy
    Wen, Lisa
    Huang, Jenq Kuen
    McConnell, Rose
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [46] Identification of novel cathepsin K inhibitors using ligand-based virtual screening and structure-based docking
    Wang, Yali
    Li, Ruolan
    Zheng, Zhihui
    Yi, Hong
    Li, Zhuorong
    RSC ADVANCES, 2016, 6 (86): : 82961 - 82968
  • [47] Advances in cathepsin S inhibitor design
    Link, JO
    Zipfel, S
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (04) : 471 - 482
  • [48] Design of cathepsin K inhibitors for osteoporosis
    Deaton, DN
    Tavares, FX
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (16) : 1639 - 1675
  • [49] IRREVERSIBLE INHIBITORS OF CATHEPSIN-B
    COLES, P
    COPP, LJ
    SMITH, RA
    SPENCER, RW
    KRANTZ, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 195 : 46 - MEDI
  • [50] Evaluation of new cathepsin B inhibitors
    Forgas, David
    Wen, Lisa
    Huang, Jenq-Kuen
    McConnell, Rose
    FASEB JOURNAL, 2014, 28 (01):